WallStreetZenWallStreetZen

NASDAQ: RLAY
Relay Therapeutics Inc Stock Ownership - Who owns Relay Therapeutics?

Insider buying vs selling

Have Relay Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sanjiv PatelPresident and CEO2024-06-302,108$5.54
$11.68kBuy
Peter RahmerChief Corporate Development Officer2024-06-302,108$5.54
$11.68kBuy
Thomas CatinazzoChief Financial Officer2024-06-279,078$6.24
$56.65kSell
Thomas CatinazzoChief Financial Officer2024-06-27295$6.26
$1.85kSell
Brian AdamsChief Legal Officer2024-06-27295$6.26
$1.85kSell
Peter RahmerChief Corporate Development Officer2024-06-27245$6.26
$1.53kSell
Donald A. BergstromPresident RD2024-06-27648$6.26
$4.06kSell
Jami RubinDirector2024-06-1042,242$5.04
$212.90kBuy
Peter RahmerChief Corporate Development Officer2024-06-0520,450$7.06
$144.38kSell
Peter RahmerChief Corporate Development Officer2024-06-0440,595$6.64
$269.55kSell

1 of 4

RLAY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLAY insiders and whales buy or sell their stock.

RLAY Shareholders

What type of owners hold Relay Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Sb Investment Advisers Uk Ltd21.02%27,904,963$230.77MInstitution
Svf Pauling Cayman Ltd21.02%27,904,963$230.77MInsider
Vanguard Group Inc8.90%11,815,669$97.72MInstitution
Third Rock Ventures Iii LP7.95%10,551,115$87.26MInsider
Blackrock Inc7.38%9,796,210$81.01MInstitution
Casdin Capital LLC5.59%7,423,574$61.39MInstitution
Price T Rowe Associates Inc5.18%6,879,597$56.89MInstitution
State Street Corp4.54%6,020,988$49.79MInstitution
Bellevue Group Ag4.46%5,926,618$49.01MInstitution
Arrowmark Colorado Holdings LLC3.02%4,005,170$33.12MInstitution

1 of 3

RLAY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLAY72.62%27.38%Net SellingNet Selling
IRON46.57%53.43%Net SellingNet Buying
AUTL65.86%0.00%
ELVN42.54%57.46%Net SellingNet Selling
CALT1.46%0.00%

Relay Therapeutics Stock Ownership FAQ

Who owns Relay Therapeutics?

Relay Therapeutics (NASDAQ: RLAY) is owned by 96.98% institutional shareholders, 36.56% Relay Therapeutics insiders, and 0.00% retail investors. Svf Pauling Cayman Ltd is the largest individual Relay Therapeutics shareholder, owning 27.90M shares representing 21.02% of the company. Svf Pauling Cayman Ltd's Relay Therapeutics shares are currently valued at $250.59M.

If you're new to stock investing, here's how to buy Relay Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.